EPIGENETIC REGULATION OF CD133 BY PROMOTER METHYLATION IN GLIOMA STEM CELLS

被引：0
|
作者：
Gopisetty, Gopal [1 ]
Sampath, Deepa [1 ]
Xu, Jihong [1 ]
Colman, Howard [1 ]
Puduvalli, Vinay [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：907 / 907
页数：1
相关论文
共 50 条
  • [21] CD133 hematopoietic stem cells in coronary ischemia
    Laughlin, Mary
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (11) : 1226 - 1227
  • [22] Potential mechanisms of CD133 in cancer stem cells
    Jang, Jae-Woo
    Song, Yeonhwa
    Kim, Se-Hyuk
    Kim, Joon
    Seo, Haeng Ran
    [J]. LIFE SCIENCES, 2017, 184 : 25 - 29
  • [23] Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
    Xing Wu
    Fenlang Wu
    Dongwen Xu
    Tao Zhang
    [J]. Journal of Neuro-Oncology, 2016, 127 : 221 - 232
  • [24] Prostate Cancer Stem Cells: The Role of CD133
    Yang, Jianhui
    Aljitawi, Omar
    Van Veldhuizen, Peter
    [J]. CANCERS, 2022, 14 (21)
  • [25] Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
    Wu, Xing
    Wu, Fenlang
    Xu, Dongwen
    Zhang, Tao
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2016, 127 (02) : 221 - 232
  • [26] Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer
    Davide Pellacani
    Richard J Packer
    Fiona M Frame
    Emma E Oldridge
    Paul A Berry
    Marie-Christine Labarthe
    Michael J Stower
    Matthew S Simms
    Anne T Collins
    Norman J Maitland
    [J]. Molecular Cancer, 10
  • [27] Transcriptional regulation of cancer stem cells marker CD133 by p53
    Park, E. K.
    Bang, S. Y.
    Yi, S. A.
    Han, J. W.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 153 - 154
  • [28] Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer
    Pellacani, Davide
    Packer, Richard J.
    Frame, Fiona M.
    Oldridge, Emma E.
    Berry, Paul A.
    Labarthe, Marie-Christine
    Stower, Michael J.
    Simms, Matthew S.
    Collins, Anne T.
    Maitland, Norman J.
    [J]. MOLECULAR CANCER, 2011, 10
  • [29] Stem cell marker CD133 affects clinical outcome in glioma patients
    Zeppernick, Felix
    Ahmadi, Rezvan
    Campos, Benito
    Dictus, Christine
    Helmke, Burkhard M.
    Becker, Natalia
    Lichter, Peter
    Unterberg, Andreas
    Radlwimmer, Bernhard
    Herold-Mende, Christel C.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (01) : 123 - 129
  • [30] Limits of CD133 as a marker of glioma self-renewing cells
    Clement, Virginie
    Dutoit, Valerie
    Marino, Denis
    Dietrich, Pierre-Yves
    Radovanovic, Ivan
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (01) : 244 - 248
12345